TRAJECTORIES OF CHANGE IN ANXIETY SEVERITY AND IMPAIRMENT DURING AND AFTER TREATMENT WITH EVIDENCE-BASED TREATMENT FOR MULTIPLE ANXIETY DISORDERS IN PRIMARY CARE

Authors

  • Jutta M. Joesch Ph.D.,

    Corresponding author
    1. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Harborview Center for Healthcare Improvement for Addictions, Mental Illness, and Medically Vulnerable Populations (CHAMMP), Seattle, Washington
    • Correspondence to: Jutta M. Joesch, Ph.D., Department of Psychiatry and Behavioral Sciences, University of Washington Medical Center, Box 359911, Seattle, WA 98104. E-mail: joesch@uw.edu

    Search for more papers by this author
  • Daniela Golinelli Ph.D.,

    1. RAND Corporation, Santa Monica, California
    Search for more papers by this author
  • Cathy D. Sherbourne Ph.D.,

    1. RAND Corporation, Santa Monica, California
    Search for more papers by this author
  • Greer Sullivan M.D., MSPH,

    1. Department of Psychiatry and VA South Central Mental Illness Research, Education, and Clinical Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas
    Search for more papers by this author
  • Murray B. Stein M.D., MPH,

    1. Departments of Psychiatry and Family and Preventive Medicine, University of California, La Jolla, California
    Search for more papers by this author
  • Michelle G. Craske Ph.D.,

    1. Departments of Psychology and Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California
    Search for more papers by this author
  • Peter P. Roy-Byrne M.D.

    1. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine and Harborview Center for Healthcare Improvement for Addictions, Mental Illness, and Medically Vulnerable Populations (CHAMMP), Seattle, Washington
    Search for more papers by this author

  • Contract grant sponsor: NIMH; contract grant numbers: U01 MH057858 and K24 MH065324 (Dr. Roy-Byrne); U01 MH058915 (Dr. Craske); U01 MH070022 (Dr. Sullivan); U01 MH070018 (Dr. Sherbourne); and U01 MH057835 and K24 MH64122 (Dr. Stein).

  • Clinical Trial Registration: Clinicaltrials.gov Identifier: NCT00347269.

Abstract

Background

Coordinated Anxiety Learning and Management (CALM) is a model for delivering evidence-based treatment for anxiety disorders in primary care. Compared to usual care, CALM produced greater improvement in anxiety symptoms. However, mean estimates can obscure heterogeneity in treatment response. This study aimed to identify (1) clusters of participants with similar patterns of change in anxiety severity and impairment (trajectory groups); and (2) characteristics that predict trajectory group membership.

Methods

The CALM randomized controlled effectiveness trial was conducted in 17 primary care clinics in four US cities in 2006–2009. 1,004 English- or Spanish-speaking patients age 18–75 with panic, generalized anxiety, social anxiety, and/or posttraumatic stress disorder participated. The Overall Anxiety Severity and Impairment Scale was administered repeatedly to 482 participants randomized to CALM treatment. Group-based trajectory modeling was applied to identify trajectory groups and multinomial logit to predict trajectory group membership.

Results

Two predicted trajectories, representing about two-thirds of participants, were below the cut-off for clinically significant anxiety a couple of months after treatment initiation. The predicted trajectory for the majority of remaining participants was below the cut-off by 9 months. A small group of participants did not show consistent improvement. Being sicker at baseline, not working, and reporting less social support were associated with less favorable trajectories.

Conclusions

There is heterogeneity in patient response to anxiety treatment. Adverse circumstances appear to hamper treatment response. To what extent anxiety symptoms improve insufficiently because adverse patient circumstances contribute to suboptimal treatment delivery, suboptimal treatment adherence, or suboptimal treatment response requires further investigation.

Ancillary